The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis

scientific article published in June 2013

The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S40264-013-0024-Z
P698PubMed publication ID23494997
P5875ResearchGate publication ID236049421

P50authorLolkje T W de Jong-van den BergQ60511270
P2093author name stringStefan Vegter
Sipke Visser
Pieter de Boer
Klaas Willem van Dijk
P2860cites workLong-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosisQ28272556
Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelinesQ33232254
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsQ33426787
Good and poor adherence: optimal cut-point for adherence measures using administrative claims dataQ33487402
Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced coughQ33668247
Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiologyQ34450874
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaQ34504490
Preventing microalbuminuria in type 2 diabetesQ34552302
Management of chronic coughQ34771784
Cough * 1: Chronic cough in adultsQ35535455
How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation informationQ35741239
Optimising drug treatment for elderly people: the prescribing cascadeQ36246842
Medication compliance and persistence: terminology and definitionsQ37072950
From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme InhibitorsQ37807235
An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitorsQ39697622
Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured populationQ39893032
ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and managementQ41156671
Compliance, persistence, and switching patterns for ACE inhibitors and ARBs.Q51533533
The prescribing cascadeQ57305021
Enalapril-induced coughQ69361289
Self-initiated modification of hypertension treatment in response to perceived problemsQ71166705
Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysisQ71666481
Delay of diagnosis and empiric treatment of angiotensin-converting enzyme inhibitor-induced cough in office practiceQ72293816
Female preponderance for lisinopril-induced cough in hypertensionQ72527442
Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseQ80969615
Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnaire survey in different medical categoriesQ81059719
P433issue6
P304page(s)435-439
P577publication date2013-06-01
P1433published inDrug SafetyQ15724462
P1476titleThe effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis
P478volume36

Reverse relations

cites work (P2860)
Q30248710Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin
Q36203442Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors
Q56524514Decreasing the Burden of Side Effects Through Positive Message Framing: an Experimental Proof-of-Concept Study
Q31148447Exploring New Zealand prescription data using sequence symmetry analyses for predicting adverse drug reactions.
Q31040399Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases
Q92276483Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics
Q40404536Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors
Q89254779Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study
Q38683173Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies
Q33673821The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study
Q91640876The provision of advice by pharmacy staff in eastern Indonesian community pharmacies

Search more.